Androski Lindsay
SEC insider (Form 3/4/5 filer). CIK 0001936604. President and CEO at Arbutus Biopharma Corp (ABUS) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WARMINSTER, PA.
Companies Androski Lindsay has filed insider reports for
- Arbutus Biopharma Corp (ABUS): Director, Officer, President and CEO
- Eloxx Pharmaceuticals, Inc. (ELOX): Director
Androski Lindsay
CIK: 0001936604
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 1, 2026ABUS
Arbutus Biopharma Corp
DispositionDirect24.7K shares at avg. $5.00$123K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
ExerciseDirect116.4K shares at avg. $3.20$373K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
Tax PaymentDirect82.5K shares at avg. $5.07$418K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
ExerciseDirect10.5K shares at avg. $4.39$46K - Feb 2, 2026ABUS
Arbutus Biopharma Corp
AwardDirect28K shares- - Mar 18, 2025ABUS
Arbutus Biopharma Corp
AwardDirectStock Option (Right to Buy)
310.4K shares- - Jan 24, 2025ELOX
Eloxx Pharmaceuticals, Inc.
ExerciseDirect3.8K shares- - Oct 16, 2024ELOX
Eloxx Pharmaceuticals, Inc.
AwardDirect12K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  ABUS Arbutus Biopharma Corp | Disposition | 24,655 | $5.00 | $123,275 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Exercise | 116,408 | $3.20 | $372,506 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Tax Payment | 82,527 | $5.07 | $418,412 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Exercise | 10,456 | $4.39 | $45,902 | Direct |
| Feb 2, 2026 | ABUS Arbutus Biopharma Corp | Award | 28,000 | - | $0 | Direct |
| Mar 18, 2025 | ABUS Arbutus Biopharma Corp | Award Stock Option (Right to Buy) | 310,422 | - | - | Direct |
| Jan 24, 2025 |  ELOX Eloxx Pharmaceuticals, Inc. | Exercise | 3,750 | - | $0 | Direct |
| Oct 16, 2024 | ELOX Eloxx Pharmaceuticals, Inc. | Award | 12,000 | - | $0 | Direct |
1-8 of 8 transactions